Optical Components Overview

  • Founded
  • 1971

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 30

Employees
  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Optical Components General Information

Description

Provider of scientific equipment and custom research mazes designed to help in conducting research. The company offers a scientific marketplace for manuscript writing, data analysis, and technology transfer services, enabling scientists and researchers to acquire resourceful materials for their research.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Other Commercial Products
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • 6 Liberty Square #2321
  • Boston, MA 02109
  • United States
+1 (888) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Optical Components Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Optical Components‘s full profile, request access.

Request a free trial

Optical Components Patents

Optical Components Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140357654-A1 Methods of treating schizophrenia with phenylalanine enamide derivative inhibitors of a4 integrin possessing a cyclobutene group Abandoned 09-Nov-2011 0000000000
CA-2854658-A1 Methods of treating schizophrenia with phenylalanine enamide derivative inhibitors of .alpha.4 integrin possessing a cyclobutene group Abandoned 09-Nov-2011 0000000000
EP-2775840-A1 Methods of treating schizophrenia with phenylalanine enamide derivative inhibitors of 4 integrin possessing a cyclobutene group Withdrawn 09-Nov-2011 0000000000
EP-2775840-A4 Methods of treating schizophrenia with phenylalanine enamide derivative inhibitors of 4 integrin possessing a cyclobutene group Withdrawn 09-Nov-2011 0000000000
US-20100076037-A1 Methods of treating neuropathic pain with agonists of ppar-gamma Abandoned 02-Nov-2006 A61K31/4436
To view Optical Components’s complete patent history, request access »

Optical Components Executive Team (1)

Name Title Board Seat Contact Info
Shuhan He Founder & Board Member
To view Optical Components’s complete executive team members history, request access »

Optical Components Board Members (1)

Name Representing Role Since
000000 00 Optical Components Founder & Board Member 000 0000
To view Optical Components’s complete board members history, request access »

Optical Components Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial